| Literature DB >> 34944597 |
Beatrix Péter1, Imre Boldizsár2,3, Gábor M Kovács2,4, Anna Erdei5,6, Zsuzsa Bajtay5,6, Alexandra Vörös1, Jeremy J Ramsden7, Ildikó Szabó8,9, Szilvia Bősze8,9, Robert Horvath1.
Abstract
Plants and fungi can be used for medical applications because of their accumulation of special bioactive metabolites. These substances might be beneficial to human health, exerting also anti-inflammatory and anticancer (antiproliferative) effects. We propose that they are mediated by influencing cellular adhesion and migration via various signaling pathways and by directly inactivating key cell adhesion surface receptor sites. The evidence for this proposition is reviewed (by summarizing the natural metabolites and their effects influencing cellular adhesion and migration), along with the classical measuring techniques used to gain such evidence. We systematize existing knowledge concerning the mechanisms of how natural metabolites affect adhesion and movement, and their role in gene expression as well. We conclude by highlighting the possibilities to screen natural compounds faster and more easily by applying new label-free methods, which also enable a far greater degree of quantification than the conventional methods used hitherto. We have systematically classified recent studies regarding the effects of natural compounds on cellular adhesion and movement, characterizing the active substances according to their organismal origin (plants, animals or fungi). Finally, we also summarize the results of recent studies and experiments on SARS-CoV-2 treatments by natural extracts affecting mainly the adhesion and entry of the virus.Entities:
Keywords: CAM; SARS-CoV-2; biosensors; cell adhesion; integrin; isolation; movement; natural compound; preparation; viability
Year: 2021 PMID: 34944597 PMCID: PMC8698624 DOI: 10.3390/biomedicines9121781
Source DB: PubMed Journal: Biomedicines ISSN: 2227-9059
Figure 1Integrin family members and their ligands. Integrins are transmembrane heterodimer molecules containing α and β subunits. The figure illustrates the association of these subunits occurring in mammalian cells. As shown, 18 α and 8 β subunits form 24 different, distinct integrins. These can be grouped in subfamilies based on evolutionary relationships (different colors of α subunits), ligand specificity and, in the case of β2 and β7 integrins, restricted expression on white blood cells. Integrins can be grouped into two larger classes that bind to cell surface cell adhesion molecules (CAMs) and ECM ligands. They can be further classified as collagen-binding integrins (α1β1, α2β1, α10β1, and α11β1), RGD-recognizing integrins (α5β1, αVβ1, αVβ3, αVβ5, αVβ6, αVβ8, and αIIbβ3), laminin-binding integrins (α3β1, α6β1, α7β1, and α6β4), and leukocyte integrins (αLβ2, αMβ2, αXβ2, and αDβ2). The β2 integrin subunit (CD18) can pair with one of the four α subunits (αL-CD11a, αM-CD11b, αX-CD11c, and αD-CD11d) [16]. The α4β1 and α9β1 integrins recognize fibronectin and VCAM-1. The β2 and β7 integrins are restrictedly expressed by leukocytes). Asterisks show the alternatively spliced cytoplasmic domains. This figure is based on the study of Hynes [10] and Yue et al. [17]. (RGD, Arg-Gly-Asp sequence; VCAM-1, a vascular cellular adhesion molecule-11).
Figure 2Adhesion molecule stimulation and mechanisms in endothelial cells. Inhibitory effect of a natural compound on cellular adhesion, typically of the human umbilical vein endothelial cell line (HUVEC), which are usually first treated with certain cytokines to stimulate the expression of CAMs.
Figure 3Stimulation mechanism for cytokine modulation in lymphocytes. In vivo, lipopolysaccharide (LPS, from Gram-negative bacteria) stimulates the immune response by interacting with its leukocyte membrane receptor, CD14 (with TLR4-MD2), to induce the generation of cytokines such as TNF- α, IL-1, IL-1 α, IL-6.
Figure 4The NF-κB pathway in endothelial cells. The compounds shown to have anti-inflammatory effects in vivo completely annulled LPS- and TNF-α-triggered nuclear translocation of NF-κB and NF-κB DNA-binding activity in endothelial cells, thus the production of cytokine receptors and ICAM, VCAM is inhibited.
Ligands and functions of different integrins of human leukocytes (RGD, Arg-Gly-Asp sequence; VCAM-1, vascular cellular adhesion molecule-1; ICAM-1, Intercellular adhesion molecule-1) [10,30,31,32,33].
| Integrin | Ligands | Functions |
|---|---|---|
| β1 | RGD, VCAM-1, E-cadherin | Adhesion |
| β2 | iC3b, fibrinogen, ICAM-1 | Adhesion, phagocytosis, apoptotic cell clearance |
| β6 | RGD, fibronectin | Adhesion, endocytosis, inflammation |
| β7 | RGD, VCAM-1 | Adhesion, inflammation |
Different modes of pathway intervention involving gene expression by natural compounds.
| Mode | Action |
|---|---|
| P1 | Inhibiting the dephosphorylation of I κB and, hence, the activation of NF-κB |
| P2 | Inhibiting translocation of activated NF-κB into the nucleus |
| P3 | Inhibition of binding of activated NF-κB to promoter sites for CAM expression |
Figure 5The interaction between the ECM, MMPs and natural compounds in breast carcinoma. Baicalein blocked the expression of MMP-2/9, thus the degradation of the extracellular matrix is also inhibited.
Three types of mechanisms inhibiting cell adhesion by blocking specific receptor sites.
| Mechanism | Action |
|---|---|
| B1 | Blocking adhesion receptors on the surface of mobile cells (e.g., leukocytes) |
| B2 | Blocking adhesion receptors on the surface of tissue cells (e.g., of the endothelium) |
| B3 | Blocking adhesion motifs in the extracellular matrix (ECM) |
Figure 6Schematic illustration of the measurement steps of flow cytometry (A) and tetrazolium-based colorimetric MTT viability tests (B). (A) Propidium iodide is a popular red-fluorescent counterstain. Living cells are not permeable to it, but dead cells are (hence acquire dark coloring) and can be detected in the population after exposure treatment of the cells. (B) The basis of the MTT assay is that the yellow, water-soluble tetrazole becomes purple, insoluble formazan by the action of mitochondrial dehydrogenase of living cells. Cytotoxic and cytostatic activities can be determined from the optical density of the control and treated cells (ICM: incomplete medium, CM: complete medium). The formazan can be conveniently extracted by DMSO for colorimetric measurement.
Absorbance-based and colorimetric cell viability and cytotoxicity assays 1.
| Cell Viability and Cytotoxicity Assays | |||||
|---|---|---|---|---|---|
| Principal | Advantage | Disadvantage | References | ||
| Dye exclusion assays | Trypan blue | membrane integrity | simple, easy to use, economic, fast | hemocytometer required, counting error, difficult to process large number of samples, cannot be distinguished healthy cells and cell function lost alive cells, toxic on mammalian cells | Jonston 2010 [ |
| Eosin | membrane integrity | economic, versatility, biosafety | time-consuming, labor-intensive, sensitive for the contamination, filling rate, and inter-user variation | Kim et al., 2016 [ | |
| Colorymetric assays | MTT | enzyme (mitochondrial) activity | easy to use, safe, high reproductibility, widly used | organic solvents required, significant well-to-well error, interaction with compounds results false positive, or false negative data | Stone et al., 2009 [ |
| MTS | easy to use, rapid, sensitive, economic, specific, inexpensive | measured absorbance level is influenced by incubation time, cell type, and cell number; optimal incubation time: 1–3 h | Berg et al., 1994 [ | ||
| XTT | results water soluble crystals, quick, sensitive, easy-to-use, safe; highly sensitive and accurate | strongly depends on reductive capacity of viable cells due to pH, cellular ion concentration, cell cycle variation, environmental factors | Scudiero et al.1988 [ | ||
| WST-1 | easy to use, high reproducibility, wildly used, no interference with phenol red, water soluble dye, no additional incubation time | relatively long incubation time (2 h) | Ishiyama et al., 1993 [ | ||
| WST-8 | not cell permeable; cells can be used after the assay; water soluble formazan | intracellular metabolic activity can influence the reduction of WST-8 | Tominaga et al., 1999 [ | ||
| LDH (lactate dehydrogenase) | enzyme (lactate dehydrogenase) activity | reliability; quick, simple evaluation, indicator of cell death | serum incompetence | Decker and Lohmann-Matthes 1988 [ | |
| SRB (sulforhodamine B) | SRB-protein interaction | simple, fast, sensitive, good linearity with cell number, metabolism independent, high reproducibility | homogenous cell suspension is required; cellular clumps and aggregates interfere with SRB | Skehan et al., 1990 [ | |
| NRU (neutral red uptake) | neutral red uptake and lysosomal accumulation | good marker for lysosomal damage, fast and simple evaluation | influenced by pollutants | Borenfreund and Puerner 1984 [ | |
| Crystal violet | binding for proteins and DNA of viable cells | quick; chemical inhibtors can be incorporated into the assay | metabolism affected compounds can not be tested, not able to measure cell proliferation rate | Feoktisova et al., 2016 [ | |
1 Trypan Blue: Staining with trypan blue is one of the oldest viability assays. In a viable cell, the intact membrane will prevent trypan blue from entering cells. In dead or dying cells, trypan blue will enter the cell, staining it blue. This method was traditionally quantified manually using microscopes and hemocytometers, making it very labor-intensive. However, the recent availability of affordable automated cell counters makes this assay less time consuming and more accurate. MTT (3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl-tetrazolium bromide) is a tetrazolium salt that gets reduced by both mitochondrial and extra-mitochondrial dehydrogenases to form insoluble blue formazan crystals, meaning a solubilization step is required before the assay can be read. MTS/XTT: MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium) and XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) substrates are similar to MTT. However, one advantage is that the reactions are carried out intracellularly in the presence of the intermediate electron acceptor phenazine methosulfate (PMS), which enhances their sensitivity. In addition, the reduced formazan product is soluble and gets released to the culture media, removing the need for the extra solubility step that is required with MTT. However, phenol red in cell culture media, fatty acids, and serum albumin have all been reported to distort data obtained from MTS, XTT, and WST assays over prolonged incubation periods. WST: Water-soluble tetrazolium salts (WSTs) are cell-impermeable tetrazolium dyes that get reduced extracellularly via plasma membrane electron transport, and combined with the electron acceptor PMS to generate water-soluble formazan dyes. LDH assay: Lactate dehydrogenase is a ubiquitous, stable cytoplasmic enzyme that converts lactate to pyruvate. If the cell membrane has been damaged, LDH, and therefore, its enzymatic activity is released from cells and can be detected in cell culture media.
Fluorometric cell viability and cytotoxicity assays 1.
| Fluorometric Assay | ||||
|---|---|---|---|---|
| Principal | Advantage | Disadvantage | References | |
| AlamarBlue (resazurin reduction assay) | enzyme (mitochondrial and other (e.g., | relatively inexpensive, sensitive, multiplexed with other methods (e.g., Caspase activity) | fluorescence interference with tested compound; direct cytotoxic effect can be occured (depending on incubation time) | O’Brien et al., 2000 [ |
| CFDA-AM (5-carboxyfluorescein diacetate, acetoxymethyl ester) | plasma membrane integrity | can be used parallel with alamarBlue on the same set of cells | fluorescence interference with tested compound | Bopp et al., 2006 [ |
| protease viability marker assay; | enzyme (aminopeptidase) activity | relatively nontoxic; multiplex with other assays, short incubation time (30–60 min) | fluorescence interference with tested compound | Niles et al., 2009 [ |
| BrdU | DNA synthesis | rapid, highly selective, results in the most reliable and direct index of proliferation, in contrast to 3H-thymidine incorporation assay, which requires a scintillation beta-counter, BrdU and EdU can be detected by antibodies, allowing analysis by flow cytometry or by immuno-histochemistry | BrdU is toxic and mutagenic, alters cell cycle, required DNA denaturation | Sidman et al., 1959 [ |
1 Alamar Blue: is a resazurin compound that gets reduced to resorufin and dihydroresorufin in viable cells. It can enter live cells so does not require cell lysis, and is stable in culture media. This assay has the added advantage that it can be measured in both fluorimetric and colorimetric plate readers. Pace et al., reported incubation time dependent cytotoxic effect [104]. Calcein-AM: Calcein-acetoxymethylester is a non-fluorescent dye that is used in both cell viability and apoptosis assays and its lipophilic, allowing easy passage through the cell membrane. Once inside the viable cell, intracellular esterases cleave the ester bonds of the acetomethoxy group, resulting in the formation of a fluorescent anionic and hydrophilic calcein dye. Non-viable cells do not contain active esterases. Also need to consider that: Cu2+, Co2+, Fe3+, Mn2+, and Ni2+ quench the fluorescent signal from calcein at physiological pH, which means care must be taken to select the appropriate cell culture media.
Luminometric cell viability and cell cytotoxicity assays 1.
| Luminometric Assay | ||||
|---|---|---|---|---|
| Principal | Advantage | Disadvantage | References | |
| ATP assay | membrane integrity | the fastest and the most sensitive assay to use; no artefacts; no plate handling step | sensitivity depends on reproducibility of pipetting | Maehara et al., 1987 [ |
| Real-time viability assay | metabolic activity | real-time measurement; multiplex | incubation time is cell type and seeding density dependent | Duellman et al., 2015 [ |
1 ATP content: there are numerously available assays that measure ATP levels as an output, when cells begin to undergo cell death process (apoptosis) or lose membrane integrity, ATP stocks become depleted through the activity of ATPases that concurrently prevent any new ATP synthesis. This leads to a rapid depletion of intracellular ATP levels. Luminescent ATP assays function by lysing cells to release ATP stores, while concurrently inhibiting ATPases. Luciferase catalyzes the oxidation of luciferin to oxyluciferin in the presence of magnesium and ATP, resulting in a luminescent signal that directly correlates with the intracellular ATP concentration.
Cell viability assays for flow cytometry and microscopic imaging 1.
| Cell Viability Assays for Flow Cytometry and Microscopic Imaging | |||||
|---|---|---|---|---|---|
| λex | Advantage | Disadvantage | References | ||
| Nucleic acid dies | Propidium iodide | 488 and 561 nm | can be added directly to the samples | not membrane permeable to live cells, not possible to use on fixed cells, can also bind to RNA not only to DNA, toxigenic and mutagenic | Suzuki et al., 1997 [ |
| 7-amino-actinomycin-D (7-AAD) | 488 and 561 nm | can be added directly to the samples, can be used in combination with formaldehyde fixation | not membrane permeable to live cells, potential carcinogen | Liu et al., 1991 [ | |
| Hoechst 33342 | 350 and 454 nm | not membrane permeable to live cells | Liu et al., 2019 [ | ||
| Helix NP™ Green, NIR and Blue | wide range from 444–640 nm | it can also be used for viability in microscopy on live cells or as a nuclear counterstain on fixed and permeabilized cells and tissue sensitive nucleic acid stain, in combination with resuzarine can be used, works with mammalian and Gram-positive and Gram-negative bacteria, can be incorporated SYTOX® stains into a number of assays for apoptosis, cell viability, and metabolism, easy-to-use. | non cell-permeable to live cells | Avlasevich et al., 2006 [ | |
| DRAQ7™ | 633 nm | can be combined with FITC, PE, and other UV or violet excitable dyes for multicolor analysis, non toxic, can be used for siRNA studies and other dynamic viablity assays | not membrane-permeable to live cells | Kerscher et al., 2019 [ | |
| Ethidium bromide | 518 nm | can be used on fixed cells, economic | not membrane-permeable, intercalates double-stranded DNA and RNA, mutagen, carcinogen, | Severini and Morgan 1991 [ | |
| SYBR® Green | 494 nm | highly selective for DNA, can be used in combination with propidium iodide | carcinogen, less mutagenic than ethidium bromide | Zipper et al., 2004 [ | |
| Acridine orange | 500 nm | cell permeable, low-cost, sensitive, rapid, intercalate to DNA, and electrostatically interact with RNA, sensitive for pH, acidic organells can be also detected, compatible for ethidium bromide and propidium iodide | nonfixable | Mirrett 1982 [ | |
| Protein binding dies | eFluor fixable dyes | wide range from 401–645 nm | traditional organic fluorescence dies, multiple application, fully compatible with most convential dies | Lekishvili et al., 2018 [ | |
| BD Horizon Brilliant dyes | polymer dyes with brighter fluorescence signal | BD Biosciences products [ | |||
| Biolegend Zombie dyes | wide range from 360–633 nm | Pardo-Garcia et al., 2015 [ | |||
| Calcein AM | 496 | cell permeant, indicator of lipid vesicle leakage, neutral substrate for MDR efflux transporters, selective for live cells; suitable for proliferating and non-proliferating cells; ideal for suspension and adherent cells, rapid, ideal for high-throughput assays; commonly used for cell tracing and in studies of endocytosis, cell migration, and gap junctions; adaptable to a wide variety of techniques, including: microplate assays, immunocytochemistry, flow cytometry, and in vivo cell tracking | Allen and Cleland 1980 [ | ||
1 Calcein-AM: Calcein-acetoxymethylester is a non-fluorescent dye that is used in both cell viability and apoptosis assays and is lipophilic, allowing easy passage through the cell membrane. Once inside the viable cell, intracellular esterases cleave the ester bonds of the acetomethoxy group, resulting in the formation of a fluorescent anionic and hydrophilic calcein dye. Non-viable cells do not contain active esterases. Also need to consider that: Cu2+, Co2+, Fe3+, Mn2+, and Ni2+ quench the fluorescent signal from calcein at physiological pH, which means care must be taken to select the appropriate cell culture media. Propidium Iodide/7-AAD: These intercalating agents are frequently used to study the cell cycle and they are membrane-impermeable, they are excluded from viable cells. This means that the fluorescence signal emitted by PI or 7-AAD in non-viable cells can be measured either by fluorescence microscopy or FACS analysis. Cell-impermeable DNA-binding dyes such (DRAQ7 from Abcam, Cambridge, UK or SYTOX from Thermo Fisher, Waltham, MA, USA) enter cells through compromised cell membranes and display strong fluorescence upon binding with DNA.
Conventional assay systems to quantify cell migration.
| Migration Assays | ||||
|---|---|---|---|---|
| Principal | Advantage | Disadvantage | References | |
| Transwell migration and invasion assay (Boyden chamber) | chemotaxis, migration, invasion | easy setup, most frequently used method, can be visualized by cytological dyes, | endpoint measurement, only adherent cells can be used, only vertical movement can be detected, must be optimized for each cell type | Menyhárt et al., 2016 [ |
| Scratch (wound healing) assay | two dimensional (2D) cell migration in confluent, monolayer cell cultures | simple, easy setup, low cost, kinetic measurement, can be combined with other techniques (e.g., gene transfections), allows high -throughput screening (HTS) | only adherent cells can be used, only horizontal movement can be detected, require relatively large cell and reagent quantities, is not ideal for chemotaxis studies | Menyhárt et al., 2016 [ |
| Cell exclusion zone assays | migration | Several kinds of barrier can be used (e.g., glass, silicone, metal, Teflon, microfabricated soft and elastic “stencils” or agarose gels), cells are visualized several manner (e.g., photomicrography or labeled with fluorescence and measured with a microplate reader), migratory capacity and interaction between two different populations can be compared, kinetic measurement, this is currently the only method that allows investigation of the effects of ECM proteins on cell motility, allows high -throughput screening (HTS) | only adherent cells can be used, only horizontal movement can be detected | Menyhárt et al., 2016 [ |
| Microcarrier bead and spheroid migration assays | migration | adherent cells and spheroids can be used, vertical and horizontal movement, plastic surface and beads can be used, microscope, time-lapse microscope and fluorescent staining can be used to count the cells, endpoint and kinetic measurement can be performed | Menyhárt et al., 2016 [ | |
| The capillary chamber migration assay | migration and morphology | adherent and suspension cells can be used, migratory behavior and morphological responses can be visualized in real time by time-lapse microscopy, endpoint and kinetic measurement can be performed, suitable for rare cell types and expensive compounds due to its small cell and volume require, liquid handling and image processing can be fully automated, allows high- throughput imaging system (HTIS) | only horizontal movement can be detected | Menyhárt et al., 2016 [ |
| Motility of individual cells | migration | adherent and suspension cells can be used, time-lapse video microscopy, 3D tracking is also possible, analysis of invasive properties of single cells as well as of populations can be performed, kinetic measurement | only horizontal movement can be detected, requires specialized microscopes and image analyzing software | Menyhárt et al., 2016 [ |
| Mechanical properties | migration and invasion in 3D structures | 3D force microscope and coated magnetic beads can be also used, high-speed video camera, video spot tracker can be applied | only adherent cells can be tested, only horizontal movement can be detected, endpoint assay | Menyhárt el al. 2016 [ |
Figure 7Multicomponent study measuring cancer cell adhesion on a natural compound-treated coating [50]. A 384-well biosensor plate was used in the experiment (left) comprising the manipulation steps in a typical well (right). Representative kinetic curves are also shown (bottom).
Figure 8Bioactivity-guided isolation of natural compounds.
Effects of plant-derived natural compounds on cell adhesion and movement. The table summarizes the applied methods and techniques as well.
| Active Substance | IUPAC Name (CAS Number) | Source | Cellular Effect | Effect Type | Molecular Mechanisms | Tested Cell Line 1, Animal | Method | Ref. |
|---|---|---|---|---|---|---|---|---|
| Cistifolin | 5-acetyl-6-hydroxy-2-(prop-1-en-2-yl)-2,3-dihydrobenzofuran-3-yl (E)-2-methylbut-2-enoate | Eupatorium purpureum (rhizome) | Inhibition of cell adhesion | No data | Modulation of integrin-dependent cell-cell and cell-protein interaction | U937 | Chromatography, | Habtemariam. 1998 |
| Ursolic acid (UA) | (3β)-3-Hydroxyurs-12-en-28-oic acid | Berries and wax-like coatings of apples, pears, etc. | Inhibition of cancer cell adhesion, invasion and migration. Preventing cancer metastasis. Inhibition on proliferation. Inhibition of cell invasion | P | ICAM-1 downregulation | MHCC-97H | MTT cell viability assay, | Xiang et al., 2015 |
| Ellagic acid | 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione |
| Antiinflammatory activity and osteoblastic activity | P | Inhibition of the effect on TNF-α-induced VCAM-1 and ICAM-1 expression | HAEC | HPLC, | Papoutsi et al., 2007 |
| Eugenol | 4-allyl-2-methoxyphenol |
| Inhibition of trophozoite adhesion. Anti- | No data | No data | GC, GC/MS, | Machado et al., 2011 | |
| Elenolic acid, | 2-[(2S,3S,4S)-3-formyl-5-methoxycarbonyl-2-methyl-3,4-dihydro-2H-pyran-4-yl]acetic acid (34422-12-3) | Decreased monocytoid cell adhesion to HUVECs. Anti-inflammatory activity | P | VCAM-1 down-expression | HUEVEC | Enzyme immunoassay (EIA), | Carluccio et al., 2003 [ | |
| Hydroxytyrosol, | 4-(2-hydroxyethyl)benzene-1,2-diol | |||||||
| Oleuropein, | (2S,3E,4S)-3-ethylidene-2-(β-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-acetic acid, 2-(3,4-dihydroxyphenyl)ethyl ester | |||||||
| Resveratrol | 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol | |||||||
| Tyrosol, | 4-(2-hydroxyethyl)phenol | |||||||
| Epigallocatechin-gallate (EGCG) |
| Inhibition of cancer cell adhesion | B | EGCG forms multilayers in the PLL-g-PEG–RGD chains, bocking the RGD motifs | HeLa | Epic BT (RWG label-free biosensor) | Peter et al., 2017 [ | |
| (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate | Inhibition of cancer cell movement (motility, average motility speed and migration) | No data | No data | HeLa | HoloMonitor M4 | Peter et al., 2015 [ | ||
| Inhibition of cancer cell adhesion to laminin | B | Binding of EGCG to laminin | B16 | Trypan blue dye exclusion assay | Suzuki and Isemura, 2001 [ | |||
| Curcumin | (1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione |
| Suppressed monocyte and HUVEC adhesion | P | Down-expression of adhesion molecules. Blocks the NF- κB signaling pathway | HUVEC | WST-1 colorimetry assay, | Kawasaki et al., 2015 |
| Dose dependent decrease of cell-cell adhesion, especially on tumor-derived spheroids. Decreased cell proliferation in cell lines with mesenchymal characteristics. Decreased the migration speed of highly migratory cells. Decreased tumor growth and aggressiveness. | No data | No data | HACAT | CyQUANT NF cell proliferation assay kit, | Santos de Campos et al., 2017 | |||
| Ethyl 3’,4’,5’-trimethoxycinamate (1), | (1) ethyl 3,4,5-trimethoxybenzoate |
| Anti-inflammatory effect. | P | Down-expression of ICAM-1 | Primary endothelial cells | Trypan blue exclusion test, | Kumar et al., 2005 |
| piperine (2) | (2) (2E,4E)-5-(benzo[d][ | Neutrophil cells from peripheral blood of healthy individuals | ||||||
| (3β,6α,9β,16β,20R,24S)-16,25-dihydroxy-3-(β-D-xylopyranosyloxy)-20,24-epoxy-9,19-cyclolanostan-6-yl β-D-glucopyranoside |
| Reduced adhesion of LPS-stimulated HUVECs for PMNs and THP-1 cells | P | Decreased the LPS-induced expression of E-selectin and VCAM-1 on the surface of HUVECs. Decreased the LPS- and TNFα-induced specific mRNA levels for E-selectin and VCAM-1. Abolished LPS- and TNFα-induced nuclear translocation of NF- κB and NF- κB DNA binding activity in endothelial cells | HUVEC | ELISA, | Zhang et al., 2003 | |
| Galangin (G) | (G) |
| Dose-dependent suppression of U937 cell adhesion to HUVEC | P | M and Q reduced the IL-1β stimulated expression of VCAM-1, ICAM-1 and E-selectin | HUVEC | Trypan blue exclusion test, | Kim et al., 2006 |
| Kaempferol (K) | (K) | |||||||
| Myricetin (M) | (M) | Berries, | ||||||
| Quercetin (Q) | (Q) | |||||||
| Baicalein | 5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one |
| Suppressed MDA-MB-231 cell adhesion to fibronectin-coated substrate | P | Down-regulated the expression of MMP-2/9 involved MAPK signaling pathway | MDA-MB-231 | MTT assay, | Wang et al., 2010 |
| Fucoidan | (2S,3S,4S,5S,6R)-4,5-dihydroxy-2,6-dimethyltetrahydro-2H-pyran-3-yl hydrogen sulfate |
| Inhibits cell adhesion to fibronectin | B | Binds to fibronectin with high affinity. Binds to MDA-MB 231 cell membrane and is internalized. Compromises α5 subunit distribution on MDA-MB-231 cell membrane | MDA-MB-231 | Western blot, | Liu et al., 2005 |
| Butein | (E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one |
| Significantly decreased TNF-α -induced U937 cell adhesion to lung epithelial cells in a dose dependent manner. Anti-inflammatory | P | Inhibition of TNF-α-induced ICAM-1 and VCAM-1 expression by inhibiting the NF- κB/ MAPK/Akt signaling pathway. Inhibited expression of ICAM-1 and VCAM-1 | A549 | Western blot, | Jang et al., 2012 |
| (1β)-6,6’,7,12-tetramethoxy-2,2’-dimethylberbaman |
| Affects the secretion and expression of adhesion molecules on cells | P | TWH-f at high concentration has significant inhibitory effect on expression and secretion of E-selectin, ICAM-1, VCAM-1. Tetrandrine did not demonstrate the same effects. | Neutrophils | Flow cytometry, | Chang et al., 1999 | |
| „Danshen” (DS) |
| SZ and HSW significantly inhibited apoptosis in HUVEC undergoing serum deprivation and TNF-α stimulation | P | Down-regulation of caspase-3-gene expression. DS and SQ significantly attenuated TNF-α-induced expression of VCAM-1 and ICAM-1 | HUVEC | Annexin-V staining, | Ling et al., 2007 | |
| „Sanchi” (SQ) | ||||||||
| „Shanzai” (SZ) | ||||||||
| „Heshouwu”(HSW) |
|
1 U937: human monocyte leukemia cells, EA.hy926: human somatic cell hybrid endothelial cells, MHCC-97H: human hepatocellular carcinoma, MHCC-97L: human hepatocellular carcinoma, HepG2: human hepatocellular carcinoma, M619: human uveal melanoma, MDA-MB-231: human breast adenocarcinoma, MCF-7: human breast adenocarcinoma, HT29: human colorectal adenocarcinoma, SW620: human colorectal adenocarcinoma, B16-F10: mouse melanoma cells, HAEC: human aorta endothelial cells, KS483: murine preosteoblastic cells, HUVEC: human umbilical vein endothelial cells, BAEC: bovine aortic endothelial cells, U937: human monocyte leukemia cells, HeLa: human cervix epithelial adenocarcinoma, THP-1: human monocytic cells, PMN: polymorph-nuclear leukocytes, A549: human lung epithelial cells, HACAT: human spontaneously transformed aneuploid immortal keratinocyte cell line, NIH-3T3: mouse fibroblast, SCC25: human oral squamous cell carcinoma, CAL27: oral adenosquamous carcinoma cell line, HCPA.BALB/c (nude mice), HFB: human synovial fibroblast, B16: mouse melanoma cell line.
Effects of animal-derived natural compounds on cell adhesion and movement. The table summarizes the applied methods and techniques as well.
| Active Substance | Source | Cellular Effect | Effect Type | Molecular Mechanisms | Tested Cell Line 1, Animal | Method | Ref. |
|---|---|---|---|---|---|---|---|
| Rhodostomin | Cell detachment. | B, P | Prevention of integrin αvβ3 interaction. | HUVEC | Cell detachment assay (Trypan blue), | Wu et al., 2002 [ | |
| Echistatin | Decreased cell adhesion | B | Prevention of αIIbβ3, αvβ3 and α5β1 integrin interactions | HeLa | Epic BT (RWG label-free biosensor) | Szekacs et al., 2018 [ |
1 HUVEC: human umbilical vein endothelial cells, HeLa: human cervix epithelial adenocarcinoma.
Effects of fungi-derived natural compounds on cell adhesion and movement. The table summarizes the applied methods and techniques as well.
| Active Substance | IUPACName (CAS Number) | Source | Cellular Effect | Effect Type | Molecular Mechanisms | Tested Cell Line 1, Animal | Method | Ref. |
|---|---|---|---|---|---|---|---|---|
|
| Inhibition of tumour cell adhesion | P | Ateration in β1-integrin expression | MT-1 | Coomassie blue staining, | Wu et al. 2006 [ | ||
| Rhodostomin |
| Inhibition of cell adhesion, platelet aggregation and the binding of fibrinogen to platelet by ARGDWN mutants | B | Prevention of integrin αIIbβ3 interaction | CHO | Mass spectrometry, | Chang et al. 2017 [ | |
| Cyclopeptolide HUN-7293 | 3-((2R,5S,8S,11S,14S,17R,20S)-8,11-diisobutyl-14-((1-methoxy-1H-indol-3-yl)methyl)-7,13,19,20-tetramethyl-18-methylene-5-((R)-2-methylheptyl)-17-((R)-2-methylhexyl)-3,6,9,12,15,21-hexaoxo-1-oxa-4,7,10,13,16,19-hexaazacyclohenicosan-2-yl)propanenitrile |
| Inhibition of VCAM-1 and ICAM-1 | P | Inhibition of the expression of VCAM-1 and ICAM-1 | HMEC-1 | ELISA | Schreiner et al. 2004 [ |
| Cytochalasin-E | (1E,4S,6R,7E,11aS,14S,14aS,15S,15aR,16aR,16bS)-14-benzyl-6-hydroxy-4,6,15,15a-tetramethyl-3,13,14,14a,15,15a,16a,16b-octahydro-[1,3]dioxacyclotridecino[4,5-d]oxireno[2,3-f]isoindole-5,10,12(4H,6H)-trione | Inhibition of cell aggregation and adhesion | No data | No data | HL-60 | Cell aggregation assay, | Takamatsu et al.n 2002 [ | |
| Cordyceptin | (2R,5S)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3-ol |
| Inhibition of motility, invasion and migration | P | Inhibition of PI3K/Akt pathway and expression of claudin family proteins. Downregulation of MMP activity | LNCaP | Wound healing migration assay, | Jeong et al. 2012 [ |
| Fusarisetin A | (3S,3aR,5S,5aS,5bS,7aS,9R,11aR,11bS,12aR)-3a-hydroxy-3-(hydroxymethyl)-2,5,9,11b-tetramethyl-3,3a,5,5a,5b,7a,8,9,10,11,11a,11b-dodecahydro-12H-benzo[4′,5′]indeno[2′,1′:3,4]furo[2,3-c]pyrrole-1,12(2H)-dione | Inhibition of migration | P | Pathway inhibition | MDA-MB-231 | Scratch wound assay, | Xu et al. 2012 [ | |
| Terrein | (4R,5S)-4,5-dihydroxy-3-((E)-prop-1-en-1-yl)cyclopent-2-en-1-one | Inhibition of adhesion and migration | P | Downregulation of MMP-2 and MMP-9 transcription. Reduction of protein levels for the Rho GTPases | MDA-MB-231 | Cell adhesion assay (crystal violet staining), | Kasorn et al. 2018 [ | |
| Ophiobolin A | (3S,3aR,3′S,5′R,6aS,9R,9aS,10aR,E)-9-hydroxy-3′,9,10a-trimethyl-5′-(2-methylprop-1-en-1-yl)-7-oxo-1,3a,4,4′,5′,6a,7,8,9,9a,10,10a-dodecahydro-2H,3′H-spiro[dicyclopenta[a,d][8]annulene-3,2′furan]-6-carbaldehyde |
| Decreased the 2D-migration potential | No data | No data | U373 MG | MTT assay, | Bury et al. 2013 [ |
| Fusicoccin A | (2S)-2-((1S,4R,5S,6S,9S,10aR,E)-4-(((2S,3R,4S,5R,6R)-4-acetoxy-3,5-dihydroxy-6-(((2-methylbut-3-en-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-6-formyl-1,5-dihydroxy-9-(methoxymethyl)-6,10a-dimethyl-1,2,4,5,6,6a,7,8,9,10a-decahydrodicyclopenta[a,d][8]annulen-3-yl)propyl acetate |
| Decreased the 2D and 3D-migration potential. | No data | No data | U373-MG | Quantitative video microscopy, | Bury et al. 2013 [ |
| Altersolanol A | (1R,2S,3R,4S)-1,2,3,4,5-pentahydroxy-7-methoxy-2-methyl-1,2,3,4-tetrahydroanthracene-9,10-dione |
| Inhibition of migration | P | Inhibition of TNFα-activated NF-κB signalling pathway. Inhibition of NF-κB-mediated MMP expression | A549 | Incucyte Live-Cell imaging system, | Teiten et al. 2013 [ |
| Sphaeropsidin A | (2R,4aR,4bR,8aS,9S)-4a,9-dihydroxy-2,8,8-trimethyl-2-vinyl-2,3,4,4a,5,6,7,8,8a,9-decahydro-10H-9,4b-(epoxymethano)phenanthrene-10,12-dione | Inhibition of migration | No data | No data | MDA-MB-231 | Wound healing assay | Wang et al. 2011 [ | |
| Gliotoxin | (3R,5aS,6S,10aR)-6-hydroxy-3-(hydroxymethyl)-2-methyl-2,3,5a,6-tetrahydro-10H-3,10a-epidithiopyrazino[1,2-a]indole-1,4-dione | Unidentified fungal strains Y90086/Y80805 | Inhibition of migration | No data | No data | HUVEC | Wound migration assay | Lee et al. 2001 [ |
| Methylthiogliotoxin | (3R,5aS,6S,10aR)-6-hydroxy-3-(hydroxymethyl)-2-methyl-3,10a-bis(methylthio)-2,3,5a,6,10,10a-hexahydropyrazino[1,2-a]indole-1,4-dione | |||||||
| Cytochalasin D | (3S,3aR,4S,6S,6aR,7E,10S,12R,13E,15R,15aS)-3-benzyl-6,12-dihydroxy-4,10,12-trimethyl-5-methylene-1,11-dioxo-2,3,3a,4,5,6,6a,9,10,11,12,15-dodecahydro-1H-cycloundeca[d]isoindol-15-yl acetate | Not mentioned (but many fungi produce, e.g., | Inhibition of actin polymerization, decreased cell motility and colonization. Inhibition of actin polymerization | No data | No data | MFC-7 | Quantitative videomicroscopy, | Hayot et al. 2006 [ |
| FTY720 (fingolimod) | 2-amino-2-(4-octylphenethyl)propane-1,3-diol |
| Inhibition of cell migration, motility and invasion | P | Inhibition of RhoA-GTPase expression | DU145 | Wound closure assay, | Zhou et al. 2006 [ |
| Staitins | ||||||||
| Lovastatin | (1S,3R,7S,8S,8aR)-8-(2-((2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (S)-2-methylbutanoate |
| Inhibition of EGF-induced migration and invasiveness | P | Inhibition of translocation of RhoA | PANC-1 | Matrigel invasion assay | Kusama et al. 2001 |
| (3S,5R,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid | Inhibition of tumor cell attachement and migration | No data | No data | F3II | Adhesion assay, | Alonso et al., 1998 [ | ||
| Suppressed the EGF-induced cell adhesion, actin filament reorganization and transmigration | P | Suppression of Rho/ROCK and FAK/paxillin signaling | ARO | Matrigel invasion assay, | Zhong et al., 2005 [ | |||
| Inhibition of adhesion. Reduced tumor cell migration, attachement and motility. Changed the tumor cell shape | P | Reduced membrane localization of Rho protein | F3II | Adhesion assay, | Farina et al., 2002 [ | |||
| Reduced migration and invasion | P | Diminished ERK signaling. Impaired the regulation of the mevalonate- and the Ras-Raf-MEK-ERK pathway. Affected the post-translational modification of H-Ras and Rac1 | U87 | Migration assay, | Afshordel et al., 2014 | |||
| Lovastatin | (1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (S)-2-methylbutanoate |
| Inhibition of invasion and migration | P | Alteration in expression of matrix-metalloproteases | M14 | Matrigel invasion assay, | Glynn et al., 2008 [ |
| Mevastatin | (1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (S)-2-methylbutanoate |
| HT144 | |||||
| Simvastain (syn) | (1S,3R,7S,8S,8aR)-8-(2-((2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate |
| SK-MEL-28 | |||||
| Macrosphelides (MSs) | ||||||||
| Macrosphelide | (4S,7E,9R,10S,13E,15R,16S)-9,15-dihydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione | Inhibition of HL-60 cell adhesion to HUVEC | B | Blocking the binding of SLex to ELAM-1 | HL-60 | Cell adhesion assay | Hayashi et al., 1995 [ | |
| B | (4S,7E,9R,10S,13E,16S)-9-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12,15-tetraone | HUVEC | ||||||
| Macrosphelide | (4S,7E,10S,13E,15R,16S)-15-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione | Inhibition of adhesion | No data | Not discussed | HL-60 | Cell adhesion assay | Takamatsu et al., 1997 [ | |
| D | (2S,6R,7E,11S,13E)-12-hydroxy-6-((S)-1-hydroxyethyl)-2,11-dimethyl-1,5,10-trioxacyclopentadeca-7,13-diene-4,9,15-trione | HUVEC | ||||||
| Macrosphelide J | (4S,9R,10S,13S,16S,E)-9-hydroxy-13-methoxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadec-7-ene-2,6,12,15-tetraone | No effect | No effect | No effect | HL-60 | Cell adhesion assay | Fukami et al., 1999 [ | |
| K | (4S,9R,10S,13S,16S,E)-13-ethoxy-9-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadec-7-ene-2,6,12,15-tetraone | |||||||
| epi-5’-hydroxymycosporulone | (4S,5R,6R,10R)-4,6-dihydroxy-10-methyl-3-methylene-2-oxaspiro[4.5]dec-8-ene-1,7-dione | |||||||
| Macroshelide A | (4S,7E,9R,10S,13E,15R,16S)-9,15-dihydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione | Inhibition of HL-60 cell adhesion to HUVEC | No data | No data | HL-60 | Cell adhesion assay with MTT staining (“Miki’s method” [ | Yamada et al., 2001, 2002, 2007 [ | |
| Macroshelide B | (4S,7E,9R,10S,13E,16S)-9-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12,15-tetraone | Inhibition of cell binding to HUVEC | B, P | Blocking the binding of sLex to E-selectin. | B16/BL6 | Adhesion assay (CFSE-labelling), | Fukami et al., 2002 | |
| Peribysins | ||||||||
| Peribysin A | (1aR,2S,3aR,7S,7aR,7bS)-1a-(3-hydroxyprop-1-en-2-yl)-7,7a-dimethyldecahydronaphtho[1,2-b]oxiren-2-ol | Inhibition of HL-60 cell adhesion to HUVEC | No data | No data | HL-60 | Cell adhesion assay with MTT staining (“Miki’s method” [ | Yamada et al., 2004, | |
1 MT-1: human breast malignant carcinoma, CHO: Chinese hamster ovary cells, K562: human immortalized myelogenous leukemia cells, HMEC-1:human dermal microvascular endothelial cells, HL-60: human leukemia cells, LNCaP: androgen-sensitive human prostate adenocarcinoma, MDA-MB-231: human breast adenocarcinoma, MCF-7: human breast adenocarcinoma, U373-MG: human glioblastoma astrocytoma, A549: human lung epithelial cells, HUVEC: human umbilical vein endothelial cells, DU145:human prostate cancer cells, PC3: human prostate cancer cells, PANC-1: human pancreatic cancer cells, F3II: sarcomatoid mammary carcinoma, ARO: anaplastic thyroid cancer cells, U87: human primary glioblastoma cells, U343: glioblastoma cells, M14: human melanoma cells, HT144: human melanoma cells, SK-MEL-28:human melanoma cells, B16/BL6: mouse melanoma cells, L5178Y-ML: mouse lymphoma cells. * Fluvastatin is a synthetic derivative of lovastatin. Experimental results of fluvastatin are only related to the work of Kusama et al. [254] ** In general, the cited publications do not detail the source of statins. In this table, the typical natural sources of these compounds are given; Pleurotus ostreatus and Penicillium citrinum. In the case of lovastatin, Aspergillus terreus is a main source as well.
Figure 9Schematic illustration of SARS-CoV-2 attachment and two possible examples of ways to inhibit this process. (A) Virus can attach to ACE2 receptor or integrins of the host cell. RGD-integrin interaction occurs in calcium-dependent manner [274]. As the result of the process, the virus penetrates into the cell and starts to copy itself. (B) Several compounds bind to the spike protein or even may alter it [275] and prevent virus-receptor attachment. (C) Lowering divalent ion concentrations in the lungs with pulmonary EDTA chelation therapy may inhibit virus-host interaction [274].